Inhibition of lung cancer growth and metastasis by DHA and its metabolite, RvD1, through miR-138-5p/FOXC1 pathway.
Xiaoming BaiJiaofang ShaoSujin ZhouZhenggang ZhaoFanghong LiRong XiangAllan Z ZhaoJinshun PanPublished in: Journal of experimental & clinical cancer research : CR (2019)
These data identified the RvD1/miR-138-5p/FOXC1 pathway as a novel mechanism by DHA and its metabolite, RvD1, and the potential of targeting such pathway as a therapeutic strategy in treating NSCLC.